SymBio Pharmaceuticals Market Cap

SymBio Pharmaceuticals has a market cap or net worth of 5.14 billion as of January 21, 2026. Its market cap has decreased by -46.64% in one year.

Market Cap

5.14B

Enterprise Value

4.01B

Revenue

1.53B

Ranking

n/a

PE Ratio

n/a

Stock Price

92.00

Market Cap Chart

Since October 20, 2011, SymBio Pharmaceuticals's market cap has decreased from 7.08B to 5.14B, a decrease of -27.45%. That is a compound annual growth rate of -2.22%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2026	5.14B	2.22%
Dec 30, 2025	5.02B	-44.92%
Dec 30, 2024	9.12B	-12.48%
Dec 29, 2023	10.42B	-58.97%
Dec 30, 2022	25.40B	-42.20%
Dec 30, 2021	43.94B	203.74%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	13.54T
HOYA Corporation	8.53T
Takeda Pharmaceutical Company	8.07T
Daiichi Sankyo Company	6.05T
Otsuka Holdings	4.69T
Astellas Pharma	3.99T
Terumo	3.18T
Shionogi &	2.42T

Market Cap Rankings